在初级Sjögren病的肥胖症
Ivette Cruz-Bautista1, Donaji Gómez-Velasco1, Ariel García-Torralba2
1Research Unit of Metabolic Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Clinical and experimental rheumatology
|September 26, 2025
概括
肥胖在初级Sjögren中很常见.
科学领域:
- 风湿病学和免疫学
- 代谢健康和自身免疫性疾病
背景情况:
- 初级斯乔格伦病 (SjD) 是一种慢性自身免疫性疾病.
- 在SjD患者中肥胖的患病率和影响尚不清楚.
研究的目的:
- 为了确定肥胖在原发性Sjögren病的流行率.
- 评估肥胖与临床特征,疾病活动,损伤和SjD症状之间的关联.
主要方法:
- 一项横向研究包括91名患有原发性Sjögren病的患者.
- 记录了人口统计,并发症,临床和血清学变量.
- 通过生物阻抗分析,使用身体质量指数 (BMI),腰围 (WC),腰比 (WHR) 和身体脂肪质量指数 (FMI) 来评估肥胖.
主要成果:
- 肥胖患病率从19.7% (BMI) 到52.7% (WHR) 不同.
- 肥胖患者 (按BMI计算) 显示抗Ro/SSA抗体的患病率较高.
- 肥胖,特别是中心肥胖,与疾病损伤 (SSDDI) 有关.
结论:
- 根据BMI,约20%的SjD患者是肥胖的,在生物阻抗分析中,这一比例上升到40%.
- 肥胖没有显著影响SjD症状或疾病活动.
- 肥胖可能与Sjögren病中疾病损伤增加有关,这表明体重管理的潜在益处.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Nephrotic Syndrome II : Assessment and Medical Management
201
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
201
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K


